Allurion Announces Three Scientific Presentations At IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
Allurion Announces Three Scientific Presentations At IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
Allurion宣佈在IFSO歐洲分會2024年上發表三場科學報告，包括有史以來的首次3年體重維持調查
New data demonstrates 80% sustained weight loss at three years with the Allurion Program and initial positive outcomes of a novel, generative AI-powered conversational agent for obesity treatment
新數據顯示，Allurion計劃在三年內持續減輕了80％的體重，並且一種用於肥胖治療的新型生成式人工智能對話藥物取得了初步的積極成果
Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced three oral scientific presentations at the 12th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter (IFSO-EC) held in Vienna, Austria on 2-4 May 2024.
致力於終結肥胖症的公司Allurion Technologies, Inc.（紐約證券交易所代碼：ALUR）今天在2024年5月2日至4日在奧地利維也納舉行的國際肥胖與代謝障礙外科聯合會——歐洲分會（IFSO-EC）第十二屆大會上宣佈了三場口頭科學演講。
Presentations include data from a survey of 133 patients across seven international obesity centers that shows patients on the Allurion Program lost just over 15% of total body weight at 4 months, and...
演講中包括一項針對七個國際肥胖中心的133名患者的調查數據，...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。